Literature DB >> 21376479

Conference on abuse liability and appeal of tobacco products: conclusions and recommendations.

Jack E Henningfield1, Dorothy K Hatsukami, Mitch Zeller, Ellen Peters.   

Abstract

The rate of initiation and progression to dependence and premature mortality are higher for tobacco products than for any other dependence producing substance. This is not explained simply by the addictiveness ("abuse liability") or by enticing product designs ("product appeal") alone, but rather by both of these factors in combination with marketing and social influences that also influence "product appeal". A working meeting of leading experts in abuse liability (AL) and product appeal was convened to examine how these disciplines could be more effectively applied to the evaluation of tobacco products for the purposes of regulation that would include setting standards for designs and contents intended to reduce the risk of initiation and dependence. It was concluded that abuse liability assessment (ALA) is a validated approach to testing pharmaceutical products but has not been extensively applied to tobacco products: such application has demonstrated feasibility, but special challenges include the diverse range of products, product complexity, and the absence of satisfactory placebo products. Consumer testing for product appeal is widely used by consumer product marketers as well as by researchers in their efforts to understand consumer product preferences and use but has not been extensively applied to tobacco products except by the tobacco industry. Recommendations for testing, methods development, and research were developed. A major recommendation was that tobacco products should be tested for AL and product appeal, and the results integrated and evaluated so as to more accurately predict risk of initiation, dependence, and persistence of use.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21376479      PMCID: PMC3105193          DOI: 10.1016/j.drugalcdep.2010.12.009

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  34 in total

1.  Conference on abuse liability assessment of CNS drugs.

Authors:  Charles R Schuster; Jack Henningfield
Journal:  Drug Alcohol Depend       Date:  2003-06-05       Impact factor: 4.492

2.  Keeping the lid on: a century of drug regulation and control.

Authors:  Joseph Spillane; William B McAllister
Journal:  Drug Alcohol Depend       Date:  2003-06-05       Impact factor: 4.492

3.  Abuse liability assessment of CNS drugs: conclusions, recommendations, and research priorities.

Authors: 
Journal:  Drug Alcohol Depend       Date:  2003-06-05       Impact factor: 4.492

4.  Risk as analysis and risk as feelings: some thoughts about affect, reason, risk, and rationality.

Authors:  Paul Slovic; Melissa L Finucane; Ellen Peters; Donald G MacGregor
Journal:  Risk Anal       Date:  2004-04       Impact factor: 4.000

5.  Solid-phase microextraction-based approach to determine free-base nicotine in trapped mainstream cigarette smoke total particulate matter.

Authors:  Clifford H Watson; Jenna S Trommel; David L Ashley
Journal:  J Agric Food Chem       Date:  2004-12-01       Impact factor: 5.279

Review 6.  Assessing internal tobacco industry knowledge of the neurobiology of tobacco dependence.

Authors:  Geoffrey Ferris Wayne; Gregory N Connolly; Jack E Henningfield
Journal:  Nicotine Tob Res       Date:  2004-12       Impact factor: 4.244

7.  Nicotine nasal spray and vapor inhaler: abuse liability assessment.

Authors:  K J Schuh; L M Schuh; J E Henningfield; M L Stitzer
Journal:  Psychopharmacology (Berl)       Date:  1997-04       Impact factor: 4.530

8.  Effects of transdermal nicotine delivery on measures of acute nicotine withdrawal.

Authors:  W B Pickworth; R V Fant; M F Butschky; J E Henningfield
Journal:  J Pharmacol Exp Ther       Date:  1996-11       Impact factor: 4.030

9.  Prying open the door to the tobacco industry's secrets about nicotine: the Minnesota Tobacco Trial.

Authors:  R D Hurt; C R Robertson
Journal:  JAMA       Date:  1998-10-07       Impact factor: 56.272

10.  Nicotine and addiction. The Brown and Williamson documents.

Authors:  J Slade; L A Bero; P Hanauer; D E Barnes; S A Glantz
Journal:  JAMA       Date:  1995-07-19       Impact factor: 56.272

View more
  25 in total

1.  Flavored and nonflavored smokeless tobacco products: rate, pattern of use, and effects.

Authors:  Andrew J Oliver; Joni A Jensen; Rachel I Vogel; Amanda J Anderson; Dorothy K Hatsukami
Journal:  Nicotine Tob Res       Date:  2012-04-22       Impact factor: 4.244

2.  A fMRI study on the impact of advertising for flavored e-cigarettes on susceptible young adults.

Authors:  Kathleen A Garrison; Stephanie S O'Malley; Ralitza Gueorguieva; Suchitra Krishnan-Sarin
Journal:  Drug Alcohol Depend       Date:  2018-03-23       Impact factor: 4.492

Review 3.  Nicotine self-administration research: the legacy of Steven R. Goldberg and implications for regulation, health policy, and research.

Authors:  Jack E Henningfield; Tracy T Smith; Bethea A Kleykamp; Reginald V Fant; Eric C Donny
Journal:  Psychopharmacology (Berl)       Date:  2016-10-21       Impact factor: 4.530

Review 4.  Research required for the effective implementation of the framework convention on tobacco control, articles 9 and 10.

Authors:  Nigel Gray; Ron Borland
Journal:  Nicotine Tob Res       Date:  2012-09-27       Impact factor: 4.244

5.  The role of cocoa as a cigarette additive: opportunities for product regulation.

Authors:  Natasha A Sokol; Ryan David Kennedy; Gregory N Connolly
Journal:  Nicotine Tob Res       Date:  2014-03-08       Impact factor: 4.244

6.  E-cigarettes: How can they help smokers quit without addicting a new generation?

Authors:  David L Ashley; Claire Adams Spears; Scott R Weaver; Jidong Huang; Michael P Eriksen
Journal:  Prev Med       Date:  2020-05-27       Impact factor: 4.018

7.  The role of subjective responses in electronic cigarette uptake and substitution in adult smokers.

Authors:  Mari S Gades; Ashley Petersen; Ellen Meier; Bruce R Lindgren; Richard J O'Connor; Peter G Shields; Dorothy Hatsukami
Journal:  Drug Alcohol Depend       Date:  2020-04-25       Impact factor: 4.492

8.  Perceived Health Risks of Snus and Medicinal Nicotine Products.

Authors:  Dorothy K Hatsukami; R I Vogel; Herb H Severson; Joni A Jensen; Richard J O'Connor
Journal:  Nicotine Tob Res       Date:  2015-09-18       Impact factor: 4.244

9.  Reasons for using flavored liquids among electronic cigarette users: A concept mapping study.

Authors:  Eric K Soule; Alexa A Lopez; Mignonne C Guy; Caroline O Cobb
Journal:  Drug Alcohol Depend       Date:  2016-07-14       Impact factor: 4.492

10.  Effects of sweet flavorings and nicotine on the appeal and sensory properties of e-cigarettes among young adult vapers: Application of a novel methodology.

Authors:  Nicholas I Goldenson; Matthew G Kirkpatrick; Jessica L Barrington-Trimis; Raina D Pang; Julia F McBeth; Mary Ann Pentz; Jonathan M Samet; Adam M Leventhal
Journal:  Drug Alcohol Depend       Date:  2016-09-22       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.